Suppr超能文献

控制炎症系统:哮喘中的Toll样受体及其靶向治疗

Holding the Inflammatory System in Check: TLRs and Their Targeted Therapy in Asthma.

作者信息

Dong Zhiyong, Xiong Lingxin, Zhang Weijie, Gibson Peter G, Wang Ting, Lu Yanjiao, Wang Guoqiang, Li Hui, Wang Fang

机构信息

Department of Pathogen Biology, Basic Medical College, Jilin University, Changchun 130021, China.

Department of Respiratory Disease, Jilin Provincial People's Hospital, Changchun 130021, China.

出版信息

Mediators Inflamm. 2016;2016:2180417. doi: 10.1155/2016/2180417. Epub 2016 May 4.

Abstract

Inflammation is a complex biological response to detrimental stimuli and can be a double-edged sword. Inflammation plays a protective role in removing pathogenic factors, but dysregulated inflammation is associated with several major fatal diseases such as asthma, cancer, and cardiovascular diseases. Asthma is a complex heterogenous disease caused by genetic and environmental factors. TLRs are the primary proteins associated with the innate and adaptive immune responses to these fatal factors and play an important role in recognizing pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), which initiates the downstream immune response. Due to the complex TLRs cascade and nowadays unsuccessful control in asthma, new studies are focused on TLRs and other potential targets in TLR cascade to minimize airway inflammation.

摘要

炎症是对有害刺激的一种复杂生物学反应,可谓一把双刃剑。炎症在清除致病因素方面发挥着保护作用,但炎症失调与哮喘、癌症和心血管疾病等几种主要致命疾病相关。哮喘是一种由遗传和环境因素引起的复杂异质性疾病。Toll样受体(TLRs)是与针对这些致命因素的固有免疫和适应性免疫反应相关的主要蛋白质,在识别病原体相关分子模式(PAMPs)和损伤相关分子模式(DAMPs)方面发挥重要作用,从而启动下游免疫反应。由于TLRs级联反应复杂,且目前哮喘控制效果不佳,新的研究聚焦于TLRs以及TLR级联反应中的其他潜在靶点,以尽量减轻气道炎症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5df5/4870363/ae718528fb7e/MI2016-2180417.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验